We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMC icon
3401
United Microelectronic
UMC
$47.5B
$33K ﹤0.01%
3,445
-27,403
-89% -$257K
ZYXI
3402
DELISTED
Zynex
ZYXI
$33K ﹤0.01%
2,322
+1,053
+83% +$14.6K
EGRX
3403
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$33K ﹤0.01%
766
-251
-25% -$10.4K
BFI
3404
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$33K ﹤0.01%
3,300
+3,021
+1,083% +$35.4K
RPT
3405
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$33K ﹤0.01%
2,557
-3,141
-55% -$39.9K
EVLO
3406
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$33K ﹤0.01%
119
+23
+24% +$5.8K
MN
3407
DELISTED
MANNING & NAPIER, INC.
MN
$33K ﹤0.01%
4,246
+1,630
+62% +$12.3K
HBMD
3408
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$33K ﹤0.01%
2,029
+708
+54% +$11.7K
QIWI
3409
DELISTED
QIWI PLC
QIWI
$33K ﹤0.01%
+3,137
New +$33.9K
AMAL icon
3410
Amalgamated Financial
AMAL
$1.5B
$32K ﹤0.01%
2,048
+384
+23% +$6.22K
ANIK icon
3411
Anika Therapeutics
ANIK
$284M
$32K ﹤0.01%
741
+211
+40% +$8.99K
AQMS icon
3412
Aqua Metals
AQMS
$9.38M
$32K ﹤0.01%
+53
New +$32.3K
BBW icon
3413
Build-A-Bear
BBW
$462M
$32K ﹤0.01%
1,864
-2,814
-60% -$33.4K
BWB icon
3414
Bridgewater Bancshares
BWB
$605M
$32K ﹤0.01%
1,997
+386
+24% +$6.46K
CECO icon
3415
Ceco Environmental
CECO
$4.32B
$32K ﹤0.01%
4,528
-423
-9% -$3.27K
CEVA icon
3416
CEVA Inc
CEVA
$859M
$32K ﹤0.01%
677
-5,883
-90% -$290K
EBIZ icon
3417
Global X E-commerce ETF
EBIZ
$29.4M
$32K ﹤0.01%
+920
New +$31.3K
ECVT icon
3418
Ecovyst
ECVT
$1.11B
$32K ﹤0.01%
2,056
-920
-31% -$14.5K
GORV
3419
DELISTED
Lazydays
GORV
$32K ﹤0.01%
49
+35
+250% +$23.9K
HAFC icon
3420
Hanmi Financial
HAFC
$948M
$32K ﹤0.01%
1,663
-2,747
-62% -$56.3K
HTBK
3421
DELISTED
Heritage Commerce
HTBK
$32K ﹤0.01%
2,894
-1,477
-34% -$17.6K
LAB icon
3422
Standard BioTools
LAB
$309M
$32K ﹤0.01%
5,147
-34,583
-87% -$185K
LBRDA icon
3423
Liberty Broadband Class A
LBRDA
$5.33B
$32K ﹤0.01%
192
-304
-61% -$47.5K
LMNR icon
3424
Limoneira
LMNR
$254M
$32K ﹤0.01%
1,835
-71
-4% -$1.3K
DFTX
3425
Definium Therapeutics
DFTX
$5.43B
$32K ﹤0.01%
+616
New +$32.3K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.